Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

Add To Watchlist

TSX:AEZS - Post Discussion

COSCIENS Biopharma Inc > 10 days until the AGM

View:

Post by prophetoffactz on Jul 02, 2024 4:09pm

10 days until the AGM

Transformational products

demand

transformational data,
transformational deals
and a transformational plan.

106

Comment

Comment by Picker1 on Jul 02, 2024 5:13pm

And yet the price keeps going down

Comment

Comment by prophetoffactz on Jul 02, 2024 9:02pm

Interesting moment. Are we watching a market failure to recognize value? Market capitalization is about ~$23.5 million with perhaps C$35 million cash. It would seem cheap trading at 67% cash. H.C. Wainwright had a C~$100 million market capitalization target for AEZS before the merger likely significantly driven by the diagnostic and the trial results for the diagnostic could be released in the ...more

106

Comment

COSCIENS Biopharma Inc